• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

FDA

FDA authorizes Q-Collar to help protect athletes’ brains

February 26, 2021 By Sean Whooley Leave a Comment

The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial […]

Filed Under: Featured, Food & Drug Administration (FDA), Neurological, Regulatory/Compliance Tagged With: concussions, FDA, Q-Collar, Q30 Sports Science, Sports Medicine

Pfizer wins FDA nod to store COVID vaccine at normal freezer temps

February 25, 2021 By Nancy Crotti Leave a Comment

The FDA announced today that it is allowing undiluted, frozen vials of the Pfizer-BioNTech COVID-19 vaccine to be transported and stored for up to two weeks at conventional temperatures commonly found in pharmaceutical freezers. The decision should allow for wider distribution of the vaccine to sites that do not have ultra-low temperature freezers. Get the […]

Filed Under: Distribution, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: BioNTech, coronavirus, COVID-19 vaccine, FDA, Pfizer

FDA analysis finds J&J’s single-done COVID-19 vaccine is safe, effective

February 24, 2021 By Sean Whooley Leave a Comment

An FDA analysis found that the single-dose COVID-19 vaccine candidate developed by Johnson & Johnson (NYSE:JNJ) is safe and effective. The analysis comes two days ahead of the FDA’s meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the EUA request for the vaccine. Johnson & Johnson submitted the EUA […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, FDA, Janssen Pharmaceuticals, Johnson & Johnson

Conformis soars on news of FDA clearance

February 22, 2021 By Sean Whooley Leave a Comment

Conformis (NSDQ:CFMS) recently received FDA 510(k) clearance for its ITotal Identity cruciate-retaining knee replacement system. According to a report from SeekingAlpha, Billerica, Mass.-based Conformis received 510(k) clearance for the ITotal Identity posterior-stabilizing knee replacement system along with the cruciate-retaining knee replacement system. The knee replacements have customized fitting properties with specificity for each patient receiving one. […]

Filed Under: Business/Financial News, Featured, Implants, Orthopedics, Wall Street Beat Tagged With: conformis, FDA

FDA issues guidelines to address COVID-19 variants

February 22, 2021 By Sean Whooley Leave a Comment

The FDA today issued guidance for medical product developers to address the emergence of variants of SARS-CoV-2, which causes COVID-19. Variants of the virus have been detected in multiple countries across the globe, including the U.S., and they pose a major threat to potentially ending the COVID-19 pandemic as protocols such as mask-wearing and hand-washing […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Pharmaceutical, Regulatory/Compliance Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, COVID-19 variants, FDA, Moderna, Pfizer

Boston Scientific has another serious recall on the same heart device

February 22, 2021 By Nancy Crotti Leave a Comment

The FDA has declared a second Class I recall within a month on a Boston Scientific implantable cardioverter defibrillator (ICD). This recall, which the company initiated with a trio of warnings in December, notified physicians that 3,350 Emblem S-ICD model A209 and A219 devices may exhibit electrical overstress while delivering high-voltage therapy. Variations in header assembly may […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Implants, Recalls, Regulatory/Compliance Tagged With: Boston Scientific, FDA

MedTech 100 roundup: Slight dip after all-time best for industry

February 22, 2021 By Sean Whooley Leave a Comment

The medtech industry’s stocks rose higher than they ever had to begin last week before eventually dropping to a slightly more normal level. MassDevice‘s MedTech 100 index ended the week (Feb. 19) at 108.72 points, marking a -1.7% dip from the 110.63-point mark set at the end of the previous week (Feb. 12). On Monday (Feb. […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Funding Roundup, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Regulatory/Compliance, Wall Street Beat Tagged With: Butterfly Network, coronavirus, COVAX, COVID-19, FDA, Henry Schein One, Joe Biden, Mainstay Medical, MedTech 100 Index, Medtronic, Personnel Moves, Retractable Technologies Inc., Zimmer Biomet

Fifth round of medtech user fee talks set to begin soon

February 19, 2021 By Nancy Crotti Leave a Comment

Every five years, the FDA, the medtech industry and the public sit down and hammer out how the agency should spend the money it collects in fees from medical device developers seeking approvals and clearances. The agency also uses the Medical Device User Fee Amendment (MDUFA) to set fees for biologics license applications, 513(g) requests for information and de […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, MDMA, MDUFA, Medical Imaging & Technology Alliance (MITA)

New FDA medtech cybersecurity chief: Guidance to debut in 2021

February 19, 2021 By Nancy Crotti Leave a Comment

The FDA’s first medical device cybersecurity chief says he will work across private and public lines to lower the threat of cyberattacks against medical devices and the healthcare systems and patients who use them. Medical device manufacturers can expect a new FDA cybersecurity draft guidance for new medical devices sometime this year, according to the […]

Filed Under: Featured, Food & Drug Administration (FDA), Health Technology, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: Cybersecurity, FDA, University of Michigan

FDA approves expanded labeling for Medtronic InterStim SureScan MRI leads

February 18, 2021 By Sean Whooley Leave a Comment

Medtronic (NYSE:MDT) announced today that it received FDA approval for expanded MRI labeling of its InterStim SNM systems. Fridley, Minn.-based Medtronic’s InterStim II and InterStim Micro sacral neuromodulation (SNM) systems that use SureScan MRI leads were approved under updated MRI guidelines allowing for a wider range of MRI scan parameters and shorter wait times between scans, […]

Filed Under: Featured, Food & Drug Administration (FDA), Gynecological, Imaging, Men's Health, Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance, Urology, Women's Health Tagged With: FDA, Medtronic

FDA lets Everlywell sell its COVID-19 home collection kit direct to consumers

February 17, 2021 By Sean Whooley Leave a Comment

Everlywell announced today that it received FDA emergency use authorization for its COVID-19 test home collection kit DTC. Under EUA, the home collection kit made by Everlywell can now be used directly by individuals who are not experiencing symptoms and have no suspected exposure and who are without a doctor’s prescription, according to a news […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Everlywell, FDA

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 85
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS